Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 50%High 0 · 0%

Taxane followed by anthracyclines vs anthracyclines followed by taxane

Disease-free survival · neoadjuvant therapy for early breast cancer

Taxane followed by anthracyclines showed no clear difference in disease‐free survival ( compared with anthracyclines followed by taxane (moderate certainty).

1 finding from 1 review

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer 2019 · Cochrane Headline outcomes only
HR 0.84 [0.65, 1.09]
1 study · 828 participants
Moderate

Taxane followed by anthracyclines vs anthracyclines followed by taxane

Disease-free survival · adjuvant therapy for early breast cancer

The review found no eligible studies for this question.

1 finding from 1 review

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found